Upgrade to SI Premium - Free Trial

Biogen (BIIB) PT Lowered to $280 at RBC Capital

January 30, 2020 1:09 PM
RBC Capital analyst Brian Abrahams lowered the price target ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change

Next Articles